Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 26486865)

Published in Stroke on October 20, 2015

Authors

Joseph P Broderick1, Olvert A Berkhemer1, Yuko Y Palesch1, Diederik W J Dippel1, Lydia D Foster1, Yvo B W E M Roos1, Aad van der Lugt1, Thomas A Tomsick1, Charles B L M Majoie1, Wim H van Zwam1, Andrew M Demchuk1, Robert J van Oostenbrugge1, Pooja Khatri1, Hester F Lingsma1, Michael D Hill1, Bob Roozenbeek1, Edward C Jauch1, Tudor G Jovin1, Bernard Yan1, Rüdiger von Kummer1, Carlos A Molina1, Mayank Goyal1, Wouter J Schonewille1, Mikael Mazighi1, Stefan T Engelter1, Craig S Anderson1, Judith Spilker1, Janice Carrozzella1, Karla J Ryckborst1, L Scott Janis1, Kit N Simpson1, IMS III Investigators, IMS II, MR CLEAN Investigators

Author Affiliations

1: From the Departments of Neurology and Rehabilitation Medicine and Radiology, University of Cincinnati Neuroscience Institute, University of Cincinnati Academic Health Center, Cincinnati, OH (J.P.B., P.K., J.S., J.C., T.A.T.); Division of Emergency Medicine (E.C.J.), Department of Public Health Sciences (Y.Y.P., L.D.F.), and Department of Healthcare Management and Leadership (K.N.S.), Medical University of South Carolina, Charleston; Calgary Stroke Program, Seaman Family MR Research Centre, Departments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada (A.M.D., M.D.H., M.G., K.J.R.); the Stroke Institute, University of Pittsburgh Medical Center, PA (T.G.J.); Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia (B.Y.); Department of Neuroradiology, Dresden University Stroke Center, University Hospital, Dresden, Germany (R.v.K.); Neurovascular Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, Barcelona, Spain (C.A.M.); Department of Neurology, University Medical Center Utrecht and the Rudolph Magnus Institute of Neurosciences, Utrecht, the Netherlands (W.J.S.); St. Antonius Hospital, Nieuwegein, the Netherlands (W.J.S.); Department of Neurology and Stroke Center, Lariboisière Hospital, Paris, France (M.M.); Department of Neurology, Basel University Hospital, Basel, Switzerland (S.T.E.); the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney (C.S.A.); and the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD (L.S.J.); the Department of Radiology (O.A.B., C.B.L.M.M.) and Neurology (Y.B.W.E.M.R.), Academic Medical Center, Amsterdam, the Netherlands; Department of Neurology (D.W.J.D., B.R.), Radiology (A.v.d.L.), and Public Health (H.F.L.), Erasmus MC University Medical Center, Rotterdam, Netherlands; and Department of Radiology (W.H.v.Z.) and N

Associated clinical trials:

Interventional Management of Stroke (IMS) III Trial (IMSIII) | NCT00359424

Articles cited by this

EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (1990) 59.70

FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J (1965) 38.57

Interobserver agreement for the assessment of handicap in stroke patients. Stroke (1988) 20.14

A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med (2014) 18.12

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78

Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70

Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med (2015) 12.06

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58

Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med (2015) 6.96

Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet (2000) 6.53

2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke (2015) 5.64

The Interventional Management of Stroke (IMS) II Study. Stroke (2007) 3.83

Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol (2014) 3.61

Methodology of the Interventional Management of Stroke III Trial. Int J Stroke (2008) 2.88

Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke (1999) 2.85

NIHSS score and arteriographic findings in acute ischemic stroke. Stroke (2005) 2.17

Relationships between angiographic findings and National Institutes of Health stroke scale score in cases of hyperacute carotid ischemic stroke. AJNR Am J Neuroradiol (2004) 1.61

MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials (2014) 1.51

Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology (2014) 1.46

Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation (2013) 1.41

Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke (2013) 1.24

State of acute endovascular therapy: report from the 12th thrombolysis, thrombectomy, and acute stroke therapy conference. Stroke (2015) 0.90

Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke (2015) 0.88

2006: a stroke odyssey. AJNR Am J Neuroradiol (2006) 0.87

Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials. Stroke (2014) 0.83

Relative Influence of Capillary Index Score, Revascularization, and Time on Stroke Outcomes From the Interventional Management of Stroke III Trial. Stroke (2015) 0.81

Early arrival at the emergency department is associated with better collaterals, smaller established infarcts and better clinical outcomes with endovascular stroke therapy: SWIFT study. J Neurointerv Surg (2015) 0.81

Articles by these authors

A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med (2014) 18.12

Two-Year Outcome after Endovascular Treatment for Acute Ischemic Stroke. N Engl J Med (2017) 1.94

MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials (2014) 1.51

Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology (2014) 1.46

Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke (2014) 1.38

Increasing use of CT angiography in interventional study sites: the IMS III experience. AJNR Am J Neuroradiol (2010) 1.20

Stent-Retriever Thrombectomy for Stroke. N Engl J Med (2015) 1.14

Endovascular therapy for ischemic stroke. N Engl J Med (2015) 1.01

Collateral Status on Baseline Computed Tomographic Angiography and Intra-Arterial Treatment Effect in Patients With Proximal Anterior Circulation Stroke. Stroke (2016) 0.90

Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke (2014) 0.89

Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience. Stroke (2014) 0.86

Letter by Mulder et al Regarding Article, "2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association". Stroke (2015) 0.79

Clot Burden Score on Baseline Computerized Tomographic Angiography and Intra-Arterial Treatment Effect in Acute Ischemic Stroke. Stroke (2016) 0.76

Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes. AJNR Am J Neuroradiol (2016) 0.75

Influence of Device Choice on the Effect of Intra-Arterial Treatment for Acute Ischemic Stroke in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands). Stroke (2016) 0.75

Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial. AJNR Am J Neuroradiol (2015) 0.75

Thrombus Permeability Is Associated With Improved Functional Outcome and Recanalization in Patients With Ischemic Stroke. Stroke (2016) 0.75

Validation of automated Alberta Stroke Program Early CT Score (ASPECTS) software for detection of early ischemic changes on non-contrast brain CT scans. Neuroradiology (2020) 0.75

Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions. J Neurointerv Surg (2014) 0.75

Admission Glucose and Effect of Intra-Arterial Treatment in Patients With Acute Ischemic Stroke. Stroke (2017) 0.75